National Taiwan University Hospital: Carcinoma, Hepatocellular trials
The registry lists 41 Carcinoma, Hepatocellular studies with National Taiwan University Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.
Phase 1 5Phase 2 12Phase 3 1No phase 26(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- HCC Risk and Monitoring in Patients With Type 2 DiabetesNot yet recruitingNCT07675187Not applicable
- SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical IndomethacinRecruitingNCT07560566Phase 2
- Safety and Clinical Efficacy of Histotripsy for Liver Cancers Adjacent to Major Intrahepatic VesselsNot yet recruitingNCT07063771Not applicable
- Ga-68 Dolacga PET Scan in HCC Under RFANot yet recruitingNCT06792097
- Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular CarcinomaRecruitingNCT06632717Phase 2
- A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular CarcinomaNot yet recruitingNCT05752890
- Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.Not yet recruitingNCT05286320Phase 1/2
- MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular CarcinomaNot yet recruitingNCT02448056
- Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular CarcinomaCompletedNCT07091942
- Peri-operative Vitamin D Therapy for HepatectomyStatus unknownNCT05650151Not applicable
- The Utility of Cell-free Methylation Markers in Blood for Hepatocellular CarcinomaStatus unknownNCT05576571
- The Utility of Cell-free DNA Methylation Markers for Hepatocellular CarcinomaStatus unknownNCT05573217
- A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma PatientsStatus unknownNCT05281926Phase 1
- The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation TherapyCompletedNCT04837742Not applicable
- Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus InfectionCompletedNCT04294498Phase 2
- P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular CarcinomaStatus unknownNCT04233840Phase 1/2
- Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT04183088Phase 2
- Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in TaiwanStatus unknownNCT03283956
- Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRICompletedNCT03267290Not applicable
- HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCCStatus unknownNCT03020342
- A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver CancersCompletedNCT02828865Not applicable
- Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular CarcinomaStatus unknownNCT02550613
- To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular CarcinomaStatus unknownNCT02074202Phase 3
- 3T MRI to Predict TACE Response of HCCStatus unknownNCT02070822
- PLA for HCC and Esophageal ca SerumStatus unknownNCT01957241
- Circulating Tumor Cells for Hepatocellular CarcinomaStatus unknownNCT01930383
- Effects of Telephone Consultations on Discharged Liver CancerCompletedNCT01595243Not applicable
- Lenalidomide as Second-line Treatment for Advanced Hepatocellular CarcinomaCompletedNCT01545804Phase 2
- The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular CarcinomaStatus unknownNCT01380392
- Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional TherapyStatus unknownNCT01281683
- Axitinib as Second-line Treatment for Advanced Hepatocellular CarcinomaCompletedNCT01273662Phase 2
- Different Genetic Features Associated With Hepatic CarcinogenesisStatus unknownNCT01247506
- A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)Status unknownNCT00960167Phase 1
- UFUR Plus Thalidomide for Advanced Hepatocellular CarcinomaCompletedNCT00519688Phase 2
- Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)CompletedNCT00464919Phase 2
- Genetic Studies in Liver Cancer PatientsStatus unknownNCT00172640
- Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular CarcinomaStatus unknownNCT00155272Phase 1/2
- Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular CarcinomaStatus unknownNCT00155103
- A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00154817Phase 2
- Searching for the Liver Cancer-Related BiomarkersStatus unknownNCT00154544
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531